Quercetin reduces inflammatory responses in LPS-stimulated cardiomyoblasts

Oxidative Medicine and Cellular Longevity

Volumn , Issue , 2012, Pages

  Angeloni, Cristina ^a   Hrelia, Silvana ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI-INFLAMMATORIES; CARDIAC CELL; CARDIOPROTECTION; CASPASE-3; CAUSATIVE AGENTS; IMMUNOBLOTTING; INDUCIBLE NITRIC OXIDE SYNTHASE (INOS); INFLAMMATORY DISEASE; INFLAMMATORY RESPONSE; LIPOPOLYSACCHARIDES; MAP KINASE; NATURALLY OCCURRING; PEROXYNITRITES; PHARMACOLOGICAL ACTIVITY; PRE-TREATMENT; PROINFLAMMATORY; PROTECTIVE AGENTS; PROTECTIVE EFFECTS; REACTIVE NITROGEN SPECIES; STRESS-ACTIVATED PROTEINS;

FATTY ACIDS; NITRIC OXIDE; PHENOLS; PHOSPHORYLATION;

CELL DEATH;

CASPASE 3; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE P38; NITRIC OXIDE; PEROXYNITRITE; QUERCETIN; REACTIVE NITROGEN SPECIES; STRESS ACTIVATED PROTEIN KINASE; ANTIINFLAMMATORY AGENT; MITOGEN ACTIVATED PROTEIN KINASE; PEROXYNITROUS ACID;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; CARDIOMYOBLAST; HEART MUSCLE CELL; HEART PROTECTION; IMMUNOBLOTTING; INFLAMMATION; NONHUMAN; OXIDATIVE STRESS; PROTEIN ANALYSIS; PROTEIN CLEAVAGE; PROTEIN PHOSPHORYLATION; RAT; SEPSIS; ANIMAL; CELL LINE; CHEMISTRY; DRUG EFFECT; ENZYMOLOGY; METABOLISM; MYOBLAST;

ANIMALS; ANTI-INFLAMMATORY AGENTS; APOPTOSIS; CASPASE 3; CELL LINE; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LIPOPOLYSACCHARIDES; MITOGEN-ACTIVATED PROTEIN KINASES; MYOBLASTS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; OXIDATIVE STRESS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PEROXYNITROUS ACID; QUERCETIN; RATS; REACTIVE NITROGEN SPECIES; SEPSIS;

EID: 84862286961     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2012/837104     Document Type: Article

References (60)

1. Parrillo J. E., Burch C., Shelhamer J. H., Parker M. M., Natanson C., Schuette W., A circulating myocardial depressant substance in humans with septic shock. Septic shock patients with a reduced ejection fraction have a circulating factor that depresses in vitro myocardial cell performance Journal of Clinical Investigation 1985 76 4 1539 1553 (Pubitemid 16193573)
2. Sharma A. C., Sepsis-induced myocardial dysfunction Shock 2007 28 3 265 269 (Pubitemid 47282016)
3. Mann D. L., Topkara V. K., Evans S., Barger P. M., Innate immunity in the adult mammalian heart: for whom the cell tolls Transactions of the American Clinical and Climatological Association 2010 121 34 51
4. von Haehling S., Schefold J. C., Lainscak M., Doehner W., Anker S. D., Inflammatory biomarkers in heart failure revisited: much more than innocent bystanders Heart Failure Clinics 2009 5 4 549 560
5. Charalambous B. M., Stephens R. C. M., Feavers I. M., Montgomery H. E., Role of bacterial endotoxin in chronic heart failure: the gut of the matter Shock 2007 28 1 15 23 (Pubitemid 46956457)
6. Hickson-Bick D. L. M., Jones C., Buja L. M., Stimulation of mitochondrial biogenesis and autophagy by lipopolysaccharide in the neonatal rat cardiomyocyte protects against programmed cell death Journal of Molecular and Cellular Cardiology 2008 44 2 411 418
7. Knapp S., Branger J., Van der Poll T., Advances in research of the inflammatory response: the importance of Toll-like receptors Wiener Medizinische Wochenschrift 2002 152 21-22 552 554 (Pubitemid 35440778)
8. Lu Y. C., Yeh W. C., Ohashi P. S., LPS/TLR4 signal transduction pathway Cytokine 2008 42 2 145 151
9. Nemoto S., Vallejo J. G., Knuefermann P., Misra A., Defreitas G., Carabello B. A., Mann D. L., Escherichia coli LPS-induced LV dysfunction: role of toll-like receptor-4 in the adult heart American Journal of Physiology 2002 282 6 H2316 H2323
10. Knuefermann P., Nemoto S., Misra A., Nozaki N., Defreitas G., Goyert S. M., Carabello B. A., Mann D. L., Vallejo J. G., CD14-deficient mice are protected against lipopolysaccharide-induced cardiac inflammation and left ventricular dysfunction Circulation 2002 106 20 2608 2615 (Pubitemid 35340698)
11. Davani E. Y., Boyd J. H., Dorscheid D. R., Wang Y., Meredith A., Chau E., Singhera G. K., Walley K. R., Cardiac ICAM-1 mediates leukocyte-dependent decreased ventricular contractility in endotoxemic mice Cardiovascular Research 2006 72 1 134 142 (Pubitemid 44310639)
12. Boyd J. H., Chau E. H., Tokunanga C., Bateman R. M., Haljan G., Davani E. Y., Wang Y., Walley K. R., Fibrinogen decreases cardiomyocyte contractility through an ICAM-1-dependent mechanism Critical Care 2008 12 1, article R2
13. Ceylan-Isik A. F., Zhao P., Zhang B., Xiao X., Su G., Ren J., Cardiac overexpression of metallothionein rescues cardiac contractile dysfunction and endoplasmic reticulum stress but not autophagy in sepsis Journal of Molecular and Cellular Cardiology 2010 48 2 367 378
14. Zhu H., Shan L., Schiller P. W., Mai A., Peng T., Histone deacetylase-3 activation promotes Tumor Necrosis Factor- (TNF- ) expression in cardiomyocytes during lipopolysaccharide stimulation Journal of Biological Chemistry 2010 285 13 9429 9436
15. Funakoshi H., Kubota T., Kawamura N., Machida Y., Feldman A. M., Tsutsui H., Shimokawa H., Takeshita A., Disruption of inducible nitric oxide synthase improves -adrenergic inotropic responsiveness but not the survival of mice with cytokine-induced cardiomyopathy Circulation Research 2002 90 9 959 965 (Pubitemid 34633861)
16. Ferdinandy P., Danial H., Ambrus I., Rothery R. A., Schulz R., Peroxynitrite is a major contributor to cytokine-induced myocardial contractile failure Circulation Research 2000 87 3 241 247 (Pubitemid 30626433)
17. Shindo T., Ikeda U., Ohkawa F., Kawahara Y., Yokoyama M., Shimada K., Nitric oxide synthesis in cardiac myocytes and fibroblasts by inflammatory cytokines Cardiovascular Research 1995 29 6 813 819
18. Champion H. C., Skaf M. W., Hare J. M., Role of nitric oxide in the pathophysiology of heart failure Heart Failure Reviews 2003 8 1 35 46 (Pubitemid 36342289)
19. Oyama J. I., Shimokawa H., Momii H., Cheng X. S., Fukuyama N., Arai Y., Egashira K., Nakazawa H., Takeshita A., Role of nitric oxide and peroxynitrite in the cytokine-induced sustained myocardial dysfunction in dogs in vivo Journal of Clinical Investigation 1998 101 10 2207 2214 (Pubitemid 28244104)
20. Lopez B. L., Liu G. L., Christopher T. A., Ma X. L., Peroxynitrite, the product of nitric oxide and superoxide, causes myocardial injury in the isolated perfused rat heart Coronary Artery Disease 1997 8 3-4 149 153 (Pubitemid 27281078)
21. Takeuchi K., Del Nido P. J., Poutias D. N., Cowan D. B., Munakata M., McGowan F. X., Vesnarinone restores contractility and calcium handling in early endotoxemia Circulation 2000 102 19, supplement 3 III365 III369
22. Yuan H., Perry C. N., Huang C., Iwai-Kanai E., Carreira R. S., Glembotski C. C., Gottlieb R. A., LPS-induced autophagy is mediated by oxidative signaling in cardiomyocytes and is associated with cytoprotection American Journal of Physiology 2009 296 2 H470 H479
23. Xia Z., Dickens M., Raingeaud J., Davis R. J., Greenberg M. E., Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis Science 1995 270 5240 1326 1331
24. Boots A. W., Haenen G. R. M. M., Bast A., Health effects of quercetin: from antioxidant to nutraceutical European Journal of Pharmacology 2008 585 2-3 325 337
25. Borska S., Gebarowska E., Wysocka T., Drag-Zalesiska M., Zabel M., The effects of quercetin vs cisplatin on proliferation and the apoptotic process in A549 and SW1271 cell lines in in vitro conditions Folia Morphologica 2004 63 1 103 105 (Pubitemid 38325224)
26. Saito A., Sugisawa A., Umegaki K., Sunagawa H., Protective effects of quercetin and its metabolites on H 2 O 2 -induced chromosomal damage to WIL2-NS cells Bioscience, Biotechnology and Biochemistry 2004 68 2 271 276 (Pubitemid 39251523)
27. Hakkinen S. H., Karenlampi S. O., Heinonen I. M., Mykkanen H. M., Torronen A. R., Content of the flavonols quercetin, myricetin, and kaempferol in 25 edible berries Journal of Agricultural and Food Chemistry 1999 47 6 2274 2279 (Pubitemid 29325110)
28. Conquer J. A., Maiani G., Azzini E., Raguzzini A., Holub B. J., Supplementation with quercetin markedly increases plasma quercetin concentration without effect on selected risk factors for heart disease in healthy subjects Journal of Nutrition 1998 128 3 593 597 (Pubitemid 28188358)
29. Moon J. H., Nakata R., Oshima S., Inakuma T., Terao J., Accumulation of quercetin conjugates in blood plasma after the short-term ingestion of onion by women American Journal of Physiology 2000 279 2 R461 R467
30. Egert S., Wolffram S., Bosy-Westphal A., Boesch-Saadatmandi C., Wagner A. E., Frank J., Rimbach G., Mueller M. J., Daily quercetin supplementation dose-dependently increases plasma quercetin concentrations in healthy humans Journal of Nutrition 2008 138 9 1615 1621
31. Angeloni C., Spencer J. P. E., Leoncini E., Biagi P. L., Hrelia S., Role of quercetin and its in vivo metabolites in protecting H9c2 cells against oxidative stress Biochimie 2007 89 1 73 82 (Pubitemid 44959282)
32. Angeloni C., Leoncini E., Malaguti M., Angelini S., Hrelia P., Hrelia S., Role of quercetin in modulating rat cardiomyocyte gene expression profile American Journal of Physiology 2008 294 3 H1233 H1243
33. Wang H., Joseph J. A., Quantifying cellular oxidative stress by dichlorofluorescein assay using microplate reader Free Radical Biology and Medicine 1999 27 5-6 612 616 (Pubitemid 29408648)
34. Nicholson D. W., Ali A., Thornberry N. A., Vaillancourt J. P., Ding C. K., Gallant M., Gareau Y., Griffin P. R., Labelle M., Lazebnik Y. A., Munday N. A., Raju S. M., Smulson M. E., Yamin T. T., Yu V. L., Miller D. K., Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis Nature 1995 376 6535 37 43
35. Landry D. W., Oliver J. A., Mechanisms of disease: the pathogenesis of vasodilatory shock New England Journal of Medicine 2001 345 8 588 595 (Pubitemid 32772102)
36. Peng T., Lu X., Lei M., Feng Q., Endothelial nitric-oxide synthase enhances lipopolysaccharide-stimulated tumor necrosis factor- expression via cAMP-mediated p38 MAPK pathway in cardiomyocytes Journal of Biological Chemistry 2003 278 10 8099 8105 (Pubitemid 36800550)
37. Haudek S. B., Spencer E., Bryant D. D., White D. J., Maass D., Horton J. W., Chen Z. J., Giroir B. P., Overexpression of cardiac I- B prevents endotoxin-induced myocardial dysfunction American Journal of Physiology 2001 280 3 H962 H968
38. Davani E. Y., Dorscheid D. R., Lee C. H., Van Breemen C., Walley K. R., Novel regulatory mechanism of cardiomyocyte contractility involving ICAM-1 and the cytoskeleton American Journal of Physiology 2004 287 3 H1013 H1022
39. Maragos C. M., Ji Ming Wang, Hrabie J. A., Oppenheim J. J., Keefer L. K., Nitric oxide/nucleophile complexes inhibit the in vitro proliferation of A375 melanoma cells via nitric oxide release Cancer Research 1993 53 3 564 568 (Pubitemid 23059437)
40. Finkel M. S., Oddis C. V., Jacob T. D., Watkins S. C., Hattler B. G., Simmons R. L., Negative inotropic effects of cytokines on the heart mediated by nitric oxide Science 1992 257 5068 387 389
41. Comini L., Boraso A., Bachetti T., Bernocchi P., Pasini E., Bastianon D., Curello S., Terracciano C. M., Ceconi C., Ferrari R., Effects of endotoxic shock on neuronal NOS and calcium transients in rat cardiac myocytes Pharmacological Research 2005 51 5 409 417 (Pubitemid 40326192)
42. Schwartz I. F., Hershkovitz R., Iaina A., Gnessin E., Wollman Y., Chernichowski T., Blum M., Levo Y., Schwartz D., Garlic attenuates nitric oxide production in rat cardiac myocytes through inhibition of inducible nitric oxide synthase and the arginine transporter CAT-2 (cationic amino acid transporter-2) Clinical Science 2002 102 5 487 493 (Pubitemid 34494187)
43. Chen T. H., Wo H. T., Wu C. C., Exendin-4 attenuates lipopolysaccharides induced inflammatory response but does not protects H9c2 cells from apoptosis Immunopharmacology and Immunotoxicology 2012 34 3 484 490
44. Dias A. S., Porawski M., Alonso M., Marroni N., Collado P. S., Gonzlez-Gallego J., Quercetin decreases oxidative stress, NF- B activation, and iNOS overexpression in liver of streptozotocin-induced diabetic rats Journal of Nutrition 2005 135 10 2299 2304 (Pubitemid 41429581)
45. Chae H. J., Chae S. W., Kim H. R., Cyclic adenosine monophosphate inhibits nitric oxide-induced apoptosis of cardiac muscle cells in a c-Jun N-terminal kinase-dependent manner Immunopharmacology and Immunotoxicology 2004 26 2 249 263
46. Albina J. E., Cui S., Mateo R. B., Reichner J. S., Nitric oxide-mediated apoptosis in murine peritoneal macrophages Journal of Immunology 1993 150 11 5080 5085 (Pubitemid 23150375)
47. Matheis G., Sherman M. P., Buckberg G. D., Haybron D. M., Young H. H., Ignarro L. J., Role of L-arginine-nitric oxide pathway in myocardial reoxygenation injury American Journal of Physiology 1992 262 2 H616 H620
48. Galea E., Feinstein D. L., Reis D. J., Induction of calcium-independent nitric oxide synthase activity in primary rat glial cultures Proceedings of the National Academy of Sciences of the United States of America 1992 89 22 10945 10949
49. Cho S. Y., Park S. J., Kwon M. J., Jeong T. S., Bok S. H., Choi W. Y., Jeong W. I., Ryu S. Y., Do S. H., Lee C. S., Song J. C., Jeong K. S., Quercetin suppresses proinflammatory cytokines production through MAP kinases and NF- B pathway in lipopolysaccharide-stimulated macrophage Molecular and Cellular Biochemistry 2003 243 1-2 153 160
50. Mu M. M., Chakravortty D., Sugiyama T., Koide N., Takahashi K., Mori I., Yoshida T., Yokochi T., The inhibitory action of quercetin on lipopolysaccharide-induced nitric oxide production in RAW 264.7 macrophage cells Journal of Endotoxin Research 2001 7 6 431 438 (Pubitemid 34048526)
51. Valen G., Yan Z. Q., Hansson G. K., Nuclear factor kappa-B and the heart Journal of the American College of Cardiology 2001 38 2 307 314 (Pubitemid 32721754)
52. Schmitz M. L., Mattioli I., Buss H., Kracht M., NF- B: a multifaceted transcription factor regulated at several levels ChemBioChem 2004 5 10 1348 1358 (Pubitemid 39371504)
53. Wright G., Singh I. S., Hasday J. D., Farrance I. K., Hall G., Cross A. S., Rogers T. B., Endotoxin stress-response in cardiomyocytes: NF- B activation and tumor necrosis factor- expression American Journal of Physiology 2002 282 3 H872 H879
54. Hall G., Singh I. S., Hester L., Hasday J. D., Rogers T. B., Inhibitor- B kinase- regulates LPS-induced TNF- production in cardiac myocytes through modulation of NF- B p65 subunit phosphorylation American Journal of Physiology 2005 289 5 H2103 H2111
55. Andréka P., Tran T., Webster K. A., Bishopric N. H., Nitric oxide and promotion of cardiac myocyte apoptosis Molecular and Cellular Biochemistry 2004 263 1 35 53 (Pubitemid 39256144)
56. Peng T., Lu X., Lei M., Moe G. W., Feng Q., Inhibition of p38 MAPK decreases myocardial TNF-alpha expression and improves myocardial function and survival in endotoxemia Cardiovascular Research 2003 59 4 893 900 (Pubitemid 38366245)
57. Liang Q., Molkentin J. D., Redefining the roles of p38 and JNK signaling in cardiac hypertrophy: dichotomy between cultured myocytes and animal models Journal of Molecular and Cellular Cardiology 2003 35 12 1385 1394 (Pubitemid 37491181)
58. Peng T., Lu X., Feng Q., NADH oxidase signaling induces cyclooxygenase-2 expression during lipopolysaccharide stimulation in cardiomyocytes The FASEB Journal 2005 19 2 293 295 (Pubitemid 40189286)
59. Chae H. J., So H. S., Chae S. W., Park J. S., Kim M. S., Oh J. M., Chung Y. T., Yang S. H., Jeong E. T., Kim H. M., Park R. K., Kim H. R., Sodium nitroprusside induces apoptosis of H9C2 cardiac muscle cells in a c-Jun N-terminal kinase-dependent manner International Immunopharmacology 2001 1 5 967 978
60. Liu C. J., Lo J. F., Kuo C. H., Chu C. H., Chen L. M., Tsai F. J., Tsai C. H., Tzang B. S., Kuo W. W., Huang C. Y., Akt mediates 17 -estradiol and/or estrogen receptor- inhibition of LPS-induced tumor necresis factor- expression and myocardial cell apoptosis by suppressing the JNK1/2-NF B pathway Journal of Cellular and Molecular Medicine 2009 13 9 B 3655 3667